Sandrine Cammas-MarionView profile
Researcher
Sandrine Cammas-Marion is a CNRS Researcher affiliated with the Institute of Chemical Sciences of Rennes (ISCR, UMR 6226 CNRS) at the National School of Chemistry of Rennes (ENSCR) and the NuMeCan Institute (U-1241 Inserm - INRA - University of Rennes 1). She has held a continuous research position with CNRS since 1995, currently splitting her time equally between ISCR and NuMeCan, focusing on the development of degradable and biocompatible nano-platforms for therapy and diagnosis. Her work bridges polymer chemistry and biomedical applications, particularly in targeted drug delivery for hepatocellular carcinoma. Her research interests include the synthesis of degradable polyesters via anionic ring-opening polymerization, design of functionalized (co)polyesters carrying targeting agents or drugs, self-assembly of amphiphilic copolymers, and the development of multifunctional nanoparticles for targeted delivery. She has made significant contributions to poly(malic acid)-based systems and stimuli-responsive nanocarriers. The recent publications highlight a strong trend toward advanced drug delivery systems, particularly using poly(malic acid) and related copolymers. Research themes include targeted delivery (via RGD or galactosamine), NIR-responsive theranostics, biocompatibility studies, and enzyme-catalyzed polymerization. Her work integrates chemical synthesis, nanoparticle formulation, in vitro and in vivo evaluation, and translational nanomedicine. Scientific expertise and recognition are evident through her extensive peer-review activities for high-impact journals and evaluation of research projects for ANR, LabEx, and regional funding bodies. She has also contributed to scientific governance through roles in doctoral schools, scientific councils, and health and safety committees. She has co-authored numerous publications and book chapters on drug delivery, polymer design, and archaeal lipids. Her work often involves collaboration with experts in pharmacology, oncology, and materials science. She has contributed to major conferences and training initiatives in high-throughput experimentation and polymer science. Laboratory and team affiliations include the ISCR at ENSCR and the NuMeCan Institute, where she collaborates on interdisciplinary projects involving drug delivery, cancer therapy, and biomaterials. Her research is embedded in a strong network of national and international scientific collaborations.










